相似文献
1
Novel beta-lactamase from Capnocytophaga sp.
Antimicrob Agents Chemother. 1990 Aug;34(8):1501-4. doi: 10.1128/AAC.34.8.1501.
2
Capnocytophaga ochracea: characterization of a plasmid-encoded extended-spectrum TEM-17 beta-lactamase in the phylum Flavobacter-bacteroides.
Antimicrob Agents Chemother. 2000 Mar;44(3):760-2. doi: 10.1128/AAC.44.3.760-762.2000.
3
Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
J Antimicrob Chemother. 1985 Jun;15 Suppl C:119-32. doi: 10.1093/jac/15.suppl_c.119.
4
In vitro susceptibility of 96 Capnocytophaga strains, including a beta-lactamase producer, to new beta-lactam antibiotics and six quinolones.
Antimicrob Agents Chemother. 1987 Aug;31(8):1283-4. doi: 10.1128/AAC.31.8.1283.
5
cfxA expression in oral clinical Capnocytophaga isolates.
Anaerobe. 2015 Oct;35(Pt B):68-71. doi: 10.1016/j.anaerobe.2015.07.005. Epub 2015 Jul 21.
6
TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli.
Antimicrob Agents Chemother. 1989 Nov;33(11):1958-63. doi: 10.1128/AAC.33.11.1958.
7
Characterization of the plasmid mediated beta-lactamase BIL-1.
J Antimicrob Chemother. 1992 Aug;30(2):119-27. doi: 10.1093/jac/30.2.119.
8
A beta-lactamase from Serratia marcescens hydrolyzing the 2-carboxypenam T-5575.
Antimicrob Agents Chemother. 1995 Sep;39(9):2132-4. doi: 10.1128/AAC.39.9.2132.
9
Antimicrobial susceptibilities and beta-lactamase characterization of Capnocytophaga species.
Antimicrob Agents Chemother. 1992 Oct;36(10):2197-200. doi: 10.1128/AAC.36.10.2197.
10
Genomic analysis reveals the presence of a class D beta-lactamase with broad substrate specificity in animal bite associated Capnocytophaga species.
Eur J Clin Microbiol Infect Dis. 2017 Apr;36(4):657-662. doi: 10.1007/s10096-016-2842-2. Epub 2016 Dec 1.
引用本文的文献
1
Infective endocarditis caused by Capnocytophaga canimorsus; a case report.
BMC Infect Dis. 2019 Nov 4;19(1):927. doi: 10.1186/s12879-019-4492-3.
2
Chromosome- and plasmid-encoded beta-lactamases in Capnocytophaga spp.
Antimicrob Agents Chemother. 2005 Sep;49(9):3940-3. doi: 10.1128/AAC.49.9.3940-3943.2005.
3
Prevalence of oropharyngeal beta-lactamase-producing Capnocytophaga spp. in pediatric oncology patients over a ten-year period.
BMC Infect Dis. 2005 May 9;5:32. doi: 10.1186/1471-2334-5-32.
4
Genetic analysis of an ambler class A extended-spectrum beta-lactamase from Capnocytophaga ochracea.
J Clin Microbiol. 2004 Feb;42(2):888-90. doi: 10.1128/JCM.42.2.888-890.2004.
5
In vitro susceptibilities of Capnocytophaga isolates to beta-lactam antibiotics and beta-lactamase inhibitors.
Antimicrob Agents Chemother. 2000 Nov;44(11):3186-8. doi: 10.1128/AAC.44.11.3186-3188.2000.
6
Capnocytophaga ochracea: characterization of a plasmid-encoded extended-spectrum TEM-17 beta-lactamase in the phylum Flavobacter-bacteroides.
Antimicrob Agents Chemother. 2000 Mar;44(3):760-2. doi: 10.1128/AAC.44.3.760-762.2000.
7
Moraxella (Branhamella) catarrhalis BRO beta-lactamase: a lipoprotein of gram-positive origin?
J Bacteriol. 1999 Aug;181(16):5090-3. doi: 10.1128/JB.181.16.5090-5093.1999.
8
Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.
Eur J Clin Microbiol Infect Dis. 1998 Apr;17(4):219-34. doi: 10.1007/BF01699978.
9
Oligonucleotide probes for detection of cephalosporinases among Bacteroides strains.
Antimicrob Agents Chemother. 1996 Apr;40(4):1014-6. doi: 10.1128/AAC.40.4.1014.
10
Genetic and biochemical analysis of a novel Ambler class A beta-lactamase responsible for cefoxitin resistance in Bacteroides species.
Antimicrob Agents Chemother. 1993 May;37(5):1028-36. doi: 10.1128/AAC.37.5.1028.
本文引用的文献
1
In vitro susceptibility of Capnocytophaga strains to 18 antimicrobial agents.
Antimicrob Agents Chemother. 1981 Aug;20(2):270-1. doi: 10.1128/AAC.20.2.270.
2
Antimicrobial susceptibility of Capnocytophaga.
Antimicrob Agents Chemother. 1981 Jan;19(1):144-6. doi: 10.1128/AAC.19.1.144.
3
The beta-lactamases of Bacteroides species.
J Antimicrob Chemother. 1981 Feb;7(2):137-46. doi: 10.1093/jac/7.2.137.
4
Properties of novel beta-lactamase produced by Bacteroides fragilis.
Antimicrob Agents Chemother. 1983 Dec;24(6):925-9. doi: 10.1128/AAC.24.6.925.
5
Comparison of polyacrylamide and agarose gel thin-layer isoelectric focusing for the characterization of beta-lactamases.
Antimicrob Agents Chemother. 1983 Aug;24(2):186-9. doi: 10.1128/AAC.24.2.186.
6
Capnocytophaga ochracea infection: two cases and a review of the published work.
J Clin Pathol. 1984 Sep;37(9):1066-70. doi: 10.1136/jcp.37.9.1066.
7
Capnocytophaga sepsis: a newly recognised clinical entity in granulocytopenic patients.
Lancet. 1980 Mar 15;1(8168 Pt 1):567-8. doi: 10.1016/s0140-6736(80)91057-0.
8
Plasmids containing one inverted repeat of Tn21 can fuse with other plasmids in the presence of Tn21 transposase.
Mol Gen Genet. 1984;195(1-2):288-93. doi: 10.1007/BF00332761.
9
Cryptic plasmids in hospital isolates of Providencia stuarti.
J Med Microbiol. 1984 Oct;18(2):277-84. doi: 10.1099/00222615-18-2-277.
10
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature. 1970 Aug 15;227(5259):680-5. doi: 10.1038/227680a0.
Zotero 插件